News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
160 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21243)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2885)
Day
2 (42)
5 (179)
6 (279)
7 (219)
8 (266)
9 (160)
11 (1)
12 (260)
13 (182)
14 (148)
15 (119)
16 (95)
19 (84)
20 (183)
21 (152)
22 (149)
23 (92)
24 (2)
26 (148)
27 (157)
28 (163)
29 (199)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
5
6
7
8
9
11
12
13
14
15
16
19
20
21
22
23
24
26
27
28
29
30
Business
KaloBios Pharmaceuticals, Inc. Announces Retirement Of David W. Pritchard, President And Chief Executive Officer
January 9, 2015
·
6 min read
Alcobra Prices Public Offering Of Ordinary Shares
January 9, 2015
·
4 min read
Drug Development
Portola Pharmaceuticals, Inc. Announces Phase 3 ANNEXA-R Study Of Andexanet Alfa And Factor Xa Inhibitor XARELTO® (Rivaroxaban) Met Primary Endpoint With High Statistical Significance
January 9, 2015
·
10 min read
Drug Development
SCYNEXIS, Inc. Receives FDA Fast Track Designation For Oral Formulation Of SCY-078 For The Treatment Of Patients With Invasive Fungal Infections
January 9, 2015
·
4 min read
China Biologic Products Adopts Stockholder Rights Plan
January 9, 2015
·
5 min read
Genetown
Johnston Blakely & Company Advises CutisPharma Inc. On Equity Financing
January 9, 2015
·
2 min read
Business
Polyphor Develops The Elastase Inhibitor POL6014 For Rare Lung Diseases Using PARI Pharma’s Eflow Technology Inhalation Device
January 9, 2015
·
4 min read
Business
AngioDynamics Reports 2015 Second Quarter Financial Results
January 9, 2015
·
8 min read
FDA
EDAP TMS S.A.'s Focal One HIFU Device Approved By Health Canada
January 9, 2015
·
3 min read
Business
NanoString Technologies Inc. Provides Update On 2014 Operational and Preliminary Financial Results
January 9, 2015
·
5 min read
Previous
8 of 16
Next